Argobio Studio, the launch platform for Europe’s best innovative science, today announced the successful seed financing of Enodia Therapeutics, a biotechnology company developing novel small-molecule ...

Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, today announced it has raised 20 ...

Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, today announced it has raised ?20.7 million (US$25 ...

The life sciences industry is buzzing about AI's potential to transform drug discovery. But at this year's J.P. Morgan Healthcare Conference, the real conversation isn't about finding the perfect ...

Eric is a second-generation farmer who was in the Navy for six years and is studying crop and soil science at Oregon State ...

The working pups won’t be out of a job any time soon, but they might get even better at their life-saving work.

A new report by HEPI and Taylor & Francis explores the potential of AI to advance translational research and accelerate the ...

Benchling, the platform for scientific progress, today announced a strategic collaboration with Lilly TuneLab, an artificial ...

Commonwealth Fusion Systems has crossed two thresholds that fusion watchers have been waiting on for years: a giant ...

General, Florian Pappenberger, says collaboration and innovation, with people at the core, are key to the Centre’s success.

The company’s new AI agent automates labor-intensive processes involved in trial document management.

Addressing the microbiome's translational gap involves understanding biological complexity and developing function-driven, patient-specific interventions.